In a never-before-seen effort 3TR sets out to fundamentally increase our knowledge of the molecular pathways and mechanisms linked to response and non-response to therapy in seven different …

The aim of 3TR is to shed new light on the factors that determine whether or not a patient is likely to respond to a given treatment. 3TR will focus on seven diseases: systemic lupus erythematosus …

The 3TR project – short for Taxonomy, Treatment, Targets, and Remission – is a groundbreaking effort to understand the shared mechanisms driving immune-mediated diseases and to pave the way …

The 3TR Asthma Biologics Study (3TR-ABC): identifying novel treatment targets in severe asthma through the response to biological therapy.

All data generated within the project will be gathered on a centralised data management platform. The latter will enable detailed and comprehensive, state-of-the-art bioinformatics and biostatistics …

Nov 13, 2023 · The 3TR-ABC study is a multicentre observational prospective cohort study platform that follows patients with severe asthma from the start of biological therapy and three years onwards.

Autoimmune, inflammatory and allergic diseases are highly heterogeneous conditions in their clinical phenotype. However, despite their heterogeneity, it has been shown that they share genetic risk, …

They propose a paradigm shift in the way we look at diseases: Promoting a scientific evidence-based rationale for treatment selection, rather than following the traditional trial and error approach, 3TR will …

This annual event brings together the world's respiratory experts to showcase all the latest advances in respiratory medicine and science.

3TR is a transdisciplinary consortium that unites experts from different areas of medicine, basic sciences and bioinformatics. Among the 69 partners are academic institutions, SMEs, pharmaceutical …